KRAS and medulloblastoma: The selected ptf1a promoter also drives conditional KRASG12D expression in cerebellum; thus, we were able to assess KRAS activity during the early stages of cerebellar development by obtaining a concomitant model of putative pediatric medulloblastoma (MDB) (Gilbertson et al., 2006).